Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 2
1988 3
1989 2
1991 1
1993 1
1994 1
1995 2
1997 3
1998 1
2000 1
2002 2
2005 1
2007 2
2008 6
2009 4
2010 3
2011 6
2012 9
2013 4
2014 11
2015 5
2016 3
2017 7
2018 5
2019 4
2020 8
2021 3
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Vaccine impact: Benefits for human health.
Doherty M, Buchy P, Standaert B, Giaquinto C, Prado-Cohrs D. Doherty M, et al. Among authors: standaert b. Vaccine. 2016 Dec 20;34(52):6707-6714. doi: 10.1016/j.vaccine.2016.10.025. Epub 2016 Oct 20. Vaccine. 2016. PMID: 27773475 Free article. Review.
Screening and prostate-cancer mortality in a randomized European study.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18. N Engl J Med. 2009. PMID: 19297566 Free article. Clinical Trial.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators. Schröder FH, et al. Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6. Lancet. 2014. PMID: 25108889 Free PMC article. Clinical Trial.
Discounting health gain: a different view.
Standaert B, Ethgen O. Standaert B, et al. J Mark Access Health Policy. 2023 Nov 2;11(1):2275350. doi: 10.1080/20016689.2023.2275350. eCollection 2023. J Mark Access Health Policy. 2023. PMID: 37937314 Free PMC article.
2. How is the economic assessment of vaccines performed today?
Standaert B, Rappuoli R. Standaert B, et al. J Mark Access Health Policy. 2017 Aug 31;5(1):1335163. doi: 10.1080/20016689.2017.1335163. eCollection 2017. J Mark Access Health Policy. 2017. PMID: 29785252 Free PMC article. Review.
Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project.
Van Baarle D, Bollaerts K, Del Giudice G, Lockhart S, Luxemburger C, Postma MJ, Timen A, Standaert B; Vaccines, Infectious Diseases in the Ageing Population (VITAL) consortium. Van Baarle D, et al. Among authors: standaert b. Vaccine. 2020 Aug 18;38(37):5896-5904. doi: 10.1016/j.vaccine.2020.07.005. Epub 2020 Jul 24. Vaccine. 2020. PMID: 32713682 Free PMC article. Review.
101 results